IHC revealed DSD treatment increased the lower expression of MUC 2 (201%), Claudin-1 (395%), Occludin (117%), and ZO-1 (495%) proteins in OXA-treated rats (P < 0.01, Fig. 4B). The gene discussed is CLDN1; the disease is disorder of sexual differentiation.